Since
2021
The Netherlands
Devices for treatment
TRL 8

Challenge

About 20% of the world’s population is affected by various degrees of chronic back pain. The total market for back pain treatment is estimated at over €50 billion with current treatment options mainly consisting of medications, like paracetamol and ibuprofen and heat patches. Other therapies include physiotherapy, acupuncture, or surgery.



Opportunity

The BlueTouch technology was originally designed by Phillips and is based on a combination of blue light and infrared warmth to stimulate blood flow and muscle repair. In this, it differentiates itself radically from current treatments for chronic pain.



Solution

When the new solution will come to market, therapists and patients alike will have access to an innovative solution to treating back pains. The effect of the blue light device can have a significant impact on chronic pain treatment options.



Status

lueTouchʼs innovative therapy is expected to demonstrate its effectiveness in a clinical trial starting soon.



Meet the team

Pieter Wijffels (1)

Pieter Wijffels

Venture Partner

Pieter joined NLC in April 2020 as a Venture Partner. Before joining NLC, he spent 15 years at Philips, bringing innovation to life across the globe. He enjoys working in fast-paced environments and supporting initiatives that truly improve people’s lives.

Marc-Derek Schönberger

Marc-Derek Schönberger

CEO